Financial Counselors Inc Bristol Myers Squibb CO Transaction History

Financial Counselors Inc

$6.67 Billion
Q3 2024

A detailed history of Financial Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Counselors Inc holds 134,577 shares of BMY stock, worth $7.77 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

134,577

Previous 139,898 3.8%

Holding current value

$7.77 Million

Previous $5.81 Million 19.88%

% of portfolio

0.1%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $211,030 - $275,361	-5,321 Reduced 3.8%	134,577 $6.96 Million
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $237,273 - $312,376	-5,895 Reduced 4.04%	139,898 $5.81 Million
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $146,434 - $166,028	-3,052 Reduced 2.05%	145,793 $7.91 Million
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $164,153 - $195,880	-3,386 Reduced 2.22%	148,845 $7.64 Million
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $17,019 - $19,030	294 Added 0.19%	152,231 $8.84 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $210,115 - $233,300	-3,298 Reduced 2.12%	151,937 $9.72 Million
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $19,581 - $22,209	-298 Reduced 0.19%	155,235 $10.8 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $142,369 - $168,586	-2,079 Reduced 1.32%	155,533 $11.2 Million
Q3 2022 Nov 01, 2022	SELL	$0.13 - $76.84 $790 - $467,110	-6,079 Reduced 3.71%	157,612 $11.2 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $703,687 - $775,006	9,690 Added 6.29%	163,691 $12.6 Million
Q1 2022 Apr 28, 2022	BUY	$61.48 - $73.72 $127,325 - $152,674	2,071 Added 1.36%	154,001 $11.2 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $983,466 - $1.15 Million	-18,338 Reduced 10.77%	151,930 $9.47 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $199,876 - $234,129	-3,378 Reduced 1.95%	170,268 $10.1 Million
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $190,682 - $207,653	-3,080 Reduced 1.74%	173,646 $11.6 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $26,346 - $29,632	444 Added 0.25%	176,726 $11.2 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $195,276 - $221,284	-3,382 Reduced 1.88%	176,282 $10.9 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $449,562 - $498,173	-7,828 Reduced 4.18%	179,664 $10.8 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $1.18 Million - $1.38 Million	21,499 Added 12.95%	187,492 $11 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $104,028 - $151,178	-2,242 Reduced 1.33%	165,993 $9.25 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $684,806 - $893,268	13,916 Added 9.02%	168,235 $10.8 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $128,010 - $151,775	2,993 Added 1.98%	154,319 $7.83 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $62,958 - $69,618	-1,411 Reduced 0.92%	151,326 $6.86 Million
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $180,119 - $214,769	-3,992 Reduced 2.55%	152,737 $7.29 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $204,060 - $264,617	-4,185 Reduced 2.6%	156,729 $8.15 Million
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $242,284 - $273,277	-4,390 Reduced 2.66%	160,914 $9.99 Million
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $927,781 - $1.16 Million	-18,361 Reduced 10.0%	165,304 $9.15 Million
Q1 2018 Apr 26, 2018	SELL	$59.92 - $68.98 $19,354 - $22,280	-323 Reduced 0.18%	183,665 $11.6 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $899 - $980	15 Added 0.01%	183,988 $11.3 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $868,767 - $1 Million	15,730 Added 9.35%	183,973 $11.7 Million
Q2 2017 Aug 10, 2017	BUY	N/A	168,243	168,243 $9.37 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Bristol Myers Squibb CO Transaction History